Behind the Scenes with CROs: What biotechs need to know

EARLY ENGAGEMENT AND INCREASED TRANSPARENCY GARNER BETTER OUTCOMES FOR BIOTECHS AND PATIENTS

Patients rely on the effective relationships between innovative biotech and CROs to bring new, life-changing therapeutics to them. Dan Burch, M.D., MBA, Global Head of PPD® Biotech, shares perspectives from leadership roles at both biotech and CROs about evolving models and how close, proactive communication can help identify innovative directions to improve efficiency and outcomes of trials, in a recent interview for the Chief Medical Officer 360 Newsletter.

The free exchange of information is a proactive way to maintain trusted relationships, identify new solutions and avoid the growth of undiscovered issues.

Daniel Burch, M.D., MBA, Global Head of PPD Biotech

Download the article below.

Contact PPD Biotech About Your Study

To request a proposal or contact your local business development representative, please complete the form above. Fields marked with * are required. PPD, Inc. and its affiliates (together “PPD”) will use the data you provide on this page for the purpose of sending you the requested information and possibly following up with you. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.